First published · Last updated
Janus Kinase Inhibitor Use in Adults Aged 65 Years and Older: A Clinical Review Across Atopic Dermatitis, Alopecia Areata, and Psoriasis
This is a clinical review article on Janus kinase inhibitor use in adults aged 65 and older, covering atopic dermatitis, alopecia areata, and psoriasis. The publisher is Elsevier BV and it was published 2026-09-01.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 4/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 6/10
- Urgency
- 1/10
Why it matters
The review addresses medication use in an older population and may inform clinicians and patients about JAK inhibitor considerations for these conditions.

